Skullcap, particularly the American species Scutellaria lateriflora, has a long history of traditional use for calming the nervous system, and modern research is beginning to explore the mechanisms behind its reputation. Studies indicate that its flavonoid compounds, including baicalin and scutellarein, may contribute to anxiolytic and antioxidant effects, with preliminary human trials suggesting notable improvements in mood and anxiety without significant sedation. Research also suggests potential anti-inflammatory and neuroprotective properties, which have drawn interest in the context of supporting overall nerve function and sleep quality. While findings are promising, much of the evidence comes from small-scale or preclinical studies, so continued research will help clarify the full scope of skullcap's benefits and its most effective applications.
Compare this supplementResearch suggests that skullcap and its key bioactive flavonoids — particularly baicalin, baicalein, and wogonin — de...
View studies →Research suggests that skullcap, particularly its active compounds baicalein, baicalin, wogonin, wogonoside, and scut...
View studies →The studies provided in this research set do not contain any findings related to skullcap or its use for anxiety reli...
View studies →Research suggests that compounds derived from Scutellaria species — particularly baicalein, baicalin, wogonin, and sc...
View studies →The single study linked here does not investigate skullcap or its effects on sleep quality in any capacity; rather, i...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 1,050 mg | Daily | antioxidant support and neuroprotection | Total daily dose used in clinical studies on oxidative stress markers |
| Capsule | 350–500 mg | Three times daily | anxiety relief and general nervous system support | Common in clinical trials using Scutellaria lateriflora standardized extract |
| Extract | 100–200 mg | As needed | acute anxiety relief and mood support | Based on RCTs including Wolfson et al. 2014 examining acute anxiolytic effects |
| Extract | 200–400 mg | Daily | anti-inflammatory support | Based on preclinical and early clinical research on baicalin-containing Scutellaria extracts |
| Liquid | 1–4 mL | Three times daily | anxiety and sleep quality | Traditional use and herbal practice guidelines for tincture preparations (1:5 ratio) |